ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.625
      -0.19%
      Bitcoin
      65,098.48
      -0.06%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bioenvision (MM) (BIVN)

      7. Bioenvision (MM) (BIVN) News

      BIVN

      Bioenvision (BIVN)

      Bioenvision (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BIVN
      DateTimeSourceHeadlineSymbolCompany
      05/15/20067:00AMBusiness WireBioenvision Reports Third Quarter 2006 Financial ResultsNASDAQ:BIVNBioenvision (MM)
      05/09/20064:01PMBusiness WireBioenvision to Host Third Quarter 2006 Financial Results Conference CallNASDAQ:BIVNBioenvision (MM)
      05/02/20067:00AMBusiness WireBioenvision to Present at the Rodman & Renshaw 3rd Annual Global Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
      04/19/20067:00AMBusiness WireBioenvision to Present at UBS Global Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
      04/05/20067:00AMBusiness WireBioenvision's Evoltra(R) Achieves High Response Rates in Adult AML; New Interim Data Presented from Phase I/II Clinical StudyNASDAQ:BIVNBioenvision (MM)
      03/20/20068:00AMBusiness WireBioenvision's Evoltra(TM) Data Selected for Oral Presentation at ASCO 2006 Annual MeetingNASDAQ:BIVNBioenvision (MM)
      02/23/20064:01PMBusiness WireBioenvision to Host Conference Call Following Positive Opinion of Clofarabine from the European Medicines AgencyNASDAQ:BIVNBioenvision (MM)
      02/23/200611:08AMBusiness WireBioenvision's Clofarabine Receives a Positive Opinion from the European Medicines Agency; Bioenvision Prepares for Marketing LaNASDAQ:BIVNBioenvision (MM)
      02/14/20067:56PMBusiness WireCORRECTING and REPLACING Bioenvision Reports Second Quarter 2006 Financial ResultsNASDAQ:BIVNBioenvision (MM)
      02/14/20067:00AMBusiness WireBioenvision Reports Second Quarter 2006 Financial ResultsNASDAQ:BIVNBioenvision (MM)
      02/06/20067:30AMBusiness WireBioenvision to Host Second Quarter 2006 Financial Results Conference CallNASDAQ:BIVNBioenvision (MM)
      01/20/20063:52PMPR Newswire (US)American Stock Exchange to Trade Options on Bioenvision, Inc.NASDAQ:BIVN
      01/05/20067:00AMBusiness WireBioenvision to Present at the 24th Annual JPMorgan Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
      11/17/20057:00AMBusiness WireFirst Patients Enrolled in Three Breast Cancer Studies for Bioenvision's Modrenal(R)NASDAQ:BIVNBioenvision (MM)
      11/14/20056:00AMBusiness WireBioenvision Reports First Quarter 2006 Financial ResultsNASDAQ:BIVNBioenvision (MM)
      11/10/20054:30PMBusiness WireBioenvision to Host First Quarter 2006 Financial Results Conference CallNASDAQ:BIVNBioenvision (MM)
      11/09/20057:00AMBusiness WireClofarabine's Duration of Response Improves Outcome for Elderly AML PatientsNASDAQ:BIVNBioenvision (MM)
      11/02/20057:00AMBusiness WireBioenvision to Present at CIBC World Markets Sixteenth Annual Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
      10/12/20057:43PMBusiness WireBioenvision Reports 2005 Year-End Financial ResultsNASDAQ:BIVNBioenvision (MM)
      09/28/20057:00AMBusiness WireBioenvision's Phase II Trial of Virostat Very Active in Hepatitis C; Phase II Results to be Presented at UBS Global Life ScienceNASDAQ:BIVNBioenvision (MM)
      09/26/20057:31PMBusiness WireBioenvision Reschedules Year-End Financial Results Conference CallNASDAQ:BIVNBioenvision (MM)
      09/22/20057:00AMBusiness WireBioenvision to Hold Fiscal 2005 Year-End Financial Results Conference Call Tuesday, September 27, 2005NASDAQ:BIVNBioenvision (MM)
      09/21/20057:00AMBusiness WireFirst Patients Enrolled in Phase II and Phase IV Breast Cancer Studies for Bioenvision's Modrenal(R)NASDAQ:BIVNBioenvision (MM)
      09/07/20057:00AMBusiness WireBioenvision to Present at UBS Global Life Sciences ConferenceNASDAQ:BIVNBioenvision (MM)
      07/01/20057:00AMBusiness WireBioenvision Reports Third Quarter Fiscal 2005 Financial ResultsNASDAQ:BIVNBioenvision (MM)
      06/30/20057:00AMBusiness WireBioenvision Receives Notification from Nasdaq Regarding Removal of ''E'' from Trading SymbolNASDAQ:BIVNBioenvision (MM)
      06/06/20057:00AMBusiness WireClofarabine Active in a Broad Range of Hematologic Cancers; Data Presented at 10th European Haematology Association -EHA- SymposNASDAQ:BIVNBioenvision (MM)
      05/06/20054:00AMBusiness WireBioenvision to Hold Fiscal 2005 Third Quarter Financial Results Conference Call Monday, May 16, 2005NASDAQ:BIVNBioenvision (MM)
      03/15/200511:47AMPR Newswire (US)SAP Business One and CompuData Selected by BioenvisionNASDAQ:BIVNBioenvision (MM)
      01/27/20051:34PMPR Newswire (US)American Stock Exchange Will Trade Options on Four SecuritiesNASDAQ:BIVN
       Showing the most relevant articles for your search:NASDAQ:BIVN